IQVIA Stock (NYSE:IQV)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$203.20

52W Range

$154.50 - $247.05

50D Avg

$175.99

200D Avg

$195.40

Market Cap

$34.55B

Avg Vol (3M)

$1.69M

Beta

1.22

Div Yield

-

IQV Company Profile


IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

89,000

IPO Date

May 09, 2013

Website

IQV Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Technology And Analytics Solutions$6.63B$6.16B$5.86B
Contract Sales And Medical Solutions$788.00M$718.00M$727.00M
Research And Development Solutions$8.90B$8.53B$8.39B

Fiscal year ends in Dec 25 | Currency in USD

IQV Financial Summary


Dec 25Dec 24Dec 23
Revenue$16.31B$15.40B$14.98B
Operating Income$2.29B$2.20B$1.98B
Net Income$1.36B$1.37B$1.36B
EBITDA$3.46B$3.45B$3.26B
Basic EPS$7.91$7.57$7.39
Diluted EPS$7.84$7.49$7.29

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 05, 26 | 9:00 AM
Q4 25Feb 05, 26 | 12:00 AM
Q3 25Oct 28, 25 | 9:00 AM

Peer Comparison


TickerCompany
WATWaters Corporation
HLNHaleon plc
RMDResMed Inc.
MTDMettler-Toledo International Inc.
HUMHumana Inc.
CAHCardinal Health, Inc.
AAgilent Technologies, Inc.
GEHCGE HealthCare Technologies Inc.
ALCAlcon Inc.
ILMNIllumina, Inc.